发明名称 TRANSDERMAL FORMULATIONS OF PERGOLIDE AND USES THEREOF
摘要 This invention provides transdermal non-patch pergolide formulations useful for the treatment of disease in an equine. The invention also provides methods for treating a disease in an equine by administering a formulation of the invention to an equine.
申请公布号 US2017095468(A1) 申请公布日期 2017.04.06
申请号 US201515314727 申请日期 2015.06.11
申请人 Eli Lilly and Company 发明人 Crawley Sara Elizabeth;Marr Amy Louise;Owens Jane Granville
分类号 A61K31/48;A61K9/08;A61K47/22;A61K9/00;A61K47/20;A61K47/10 主分类号 A61K31/48
代理机构 代理人
主权项 1. A formulation comprising pergolide or a salt thereof, and a solvent system comprising one or more solvents selected from dimethyl sulfoxide, N-methylpyrrolidone, dimethylformamide, tetrahydrofuran, benzyl alcohol, acidic water, polypropylene glycol, methanol, a polyoxyethylene sorbitan monoester, water with about 40% of a cyclodextrin, dimethyl isosorbide, a caprylic/capric acid glyceride, or a suitable C8-C10 polyglycolized glyceride, wherein the solubility of said pergolide or salt thereof in said solvent system is 5 mg/ml or higher.
地址 Indianapolis IN US